ConductScience.org, home

Paper9673281

Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia.

Spencer Valero LM and 6 others. Infect Immun, 1998. Cited by 41 papers, by iCite.

Cite this record

ConductScience Library. Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia. Papers, record 9673281. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9673281

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Passive immunization with antibodies against three distinct epitopes on Plasmodium yoelii merozoite surface protein 1 suppresses parasitemia.
PubMed
Journal
Infect Immun
PubMed
Year
1998
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
41
iCite
Relative citation ratio, by iCite
0.95
iCite
Revised in PubMed
2025-05-29
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Spencer Valero LML M
2Ogun SAS A
3Fleck SLS L
4Ling ITI T
5Scott-Finnigan TJT J
6Blackman MJM J
7Holder AAA A

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, ProtozoanMajor topic
Antigens, ProtozoanMajor topic
Antigens, SurfaceMajor topic
Epitopes, B-LymphocyteMajor topic
Immunization, PassiveMajor topic
MalariaMajor topic
ParasitemiaMajor topic
Plasmodium yoeliiMajor topic
Protein PrecursorsMajor topic
Protozoan ProteinsMajor topic
Animals
Antibodies, Monoclonal
Enzyme-Linked Immunosorbent Assay
Female
Merozoite Surface Protein 1
Mice
Mice, Inbred BALB C
Recombinant Fusion Proteins

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
MC_U117532067Medical Research CouncilUnited KingdomPubMed

Source PubMed

Download CSV of grants

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17360274Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite.Nature1980https://conductscience.org/library/papers/7360274PubMed
29362529Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies.J Exp Med1997https://conductscience.org/library/papers/9362529PubMed
36752328Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody.J Exp Med1982https://conductscience.org/library/papers/6752328PubMed
46652973Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen.Clin Exp Immunol1983https://conductscience.org/library/papers/6652973PubMed
56718053Characterization of a high molecular weight protective antigen of Plasmodium yoelii.Parasitology1984https://conductscience.org/library/papers/6718053PubMed
66725950Passive immunization against murine malaria with an IgG3 monoclonal antibody.J Immunol1984https://conductscience.org/library/papers/6725950PubMed
76749183Processing of a major parasite surface glycoprotein during the ultimate stages of differentiation in Plasmodium knowlesi.Mol Biochem Parasitol1984https://conductscience.org/library/papers/6749183PubMed
84031496Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies.J Immunol1985https://conductscience.org/library/papers/4031496PubMed
92437453Fragments of the polymorphic Mr 185,000 glycoprotein from the surface of isolated Plasmodium falciparum merozoites form an antigenic complex.Mol Biochem Parasitol1987https://conductscience.org/library/papers/2437453PubMed
103047011Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.Gene1988https://conductscience.org/library/papers/3047011PubMed
112477452
A protective monoclonal antibody recognizes an epitope in the carboxyl-terminal cysteine-rich domain in the precursor of the major merozoite surface antigen of the rodent malarial parasite, Plasmodium yoelii.
J Immunol1989https://conductscience.org/library/papers/2477452PubMed
122797063Cloning and analysis of the gene encoding the 230-kilodalton merozoite surface antigen of Plasmodium yoelii.Mol Biochem Parasitol1989https://conductscience.org/library/papers/2797063PubMed
131694225A single fragment of a malaria merozoite surface protein remains on the parasite during red cell invasion and is the target of invasion-inhibiting antibodies.J Exp Med1990https://conductscience.org/library/papers/1694225PubMed
141894361Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii.Infect Immun1991https://conductscience.org/library/papers/1894361PubMed
151775158Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains.Mol Biochem Parasitol1991https://conductscience.org/library/papers/1775158PubMed
168363656A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.Infect Immun1993https://conductscience.org/library/papers/8363656PubMed
177516416Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.J Exp Med1994https://conductscience.org/library/papers/7516416PubMed
188015856Immunization against malaria with a recombinant protein.Parasite Immunol1994https://conductscience.org/library/papers/8015856PubMed
197602100Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria.J Immunol1995https://conductscience.org/library/papers/7602100PubMed
208538682Processing of the Plasmodium chabaudi chabaudi AS merozoite surface protein 1 in vivo and in vitro.Mol Biochem Parasitol1995https://conductscience.org/library/papers/8538682PubMed

See all 33 referencesDownload CSV of references

Cited by21

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 41 citations.

PMIDTitleJournalYearIn PapersSource
38720925Antimalarial evaluation of alkyl-linked bis-thiadiazine derivatives in murine model infected with two Plasmodium strains.ADMET DMPK2024https://conductscience.org/library/papers/38720925PubMed
36685595Host-parasite interactions during Plasmodium infection: Implications for immunotherapies.Front Immunol2022https://conductscience.org/library/papers/36685595PubMed
30811498Plasmodium-specific antibodies block in vivo parasite growth without clearing infected red blood cells.PLoS Pathog2019https://conductscience.org/library/papers/30811498PubMed
29397427Poly(I:C) adjuvant strongly enhances parasite-inhibitory antibodies and Th1 response against Plasmodium falciparum merozoite surface protein-1 (42-kDa fragment) in BALB/c mice.Med Microbiol Immunol2018https://conductscience.org/library/papers/29397427PubMed
27708348A chimeric protein-based malaria vaccine candidate induces robust T cell responses against Plasmodium vivax MSP119.Sci Rep2016https://conductscience.org/library/papers/27708348PubMed
24403012The structure of Plasmodium yoelii merozoite surface protein 119, antibody specificity and implications for malaria vaccine design.Open Biol2014https://conductscience.org/library/papers/24403012PubMed
23836419Redefining an epitope of a malaria vaccine candidate, with antibodies against the N-terminal MSA-2 antigen of Plasmodium harboring non-natural peptide bonds.Amino Acids2013https://conductscience.org/library/papers/23836419PubMed
23749994Antimalarial activity of cupredoxins: the interaction of Plasmodium merozoite surface protein 119 (MSP119) and rusticyanin.J Biol Chem2013https://conductscience.org/library/papers/23749994PubMed
22343045
The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)).
Exp Parasitol2012https://conductscience.org/library/papers/22343045PubMed
21931852T cell epitope regions of the P. falciparum MSP1-33 critically influence immune responses and in vitro efficacy of MSP1-42 vaccines.PLoS One2011https://conductscience.org/library/papers/21931852PubMed
21920045
The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
Malar J2011https://conductscience.org/library/papers/21920045PubMed
20146804Suppressive and additive effects in protection mediated by combinations of monoclonal antibodies specific for merozoite surface protein 1 of Plasmodium yoelii.Malar J2010https://conductscience.org/library/papers/20146804PubMed
19691552Fc-receptors and immunity to malaria: from models to vaccines.Parasite Immunol2009https://conductscience.org/library/papers/19691552PubMed
19116303Prediction of merozoite surface protein 1 and apical membrane antigen 1 vaccine efficacies against Plasmodium chabaudi malaria based on prechallenge antibody responses.Clin Vaccine Immunol2009https://conductscience.org/library/papers/19116303PubMed
17938224
Malaria vaccine-related benefits of a single protein comprising Plasmodium falciparum apical membrane antigen 1 domains I and II fused to a modified form of the 19-kilodalton C-terminal fragment of merozoite surface protein 1.
Infect Immun2007https://conductscience.org/library/papers/17938224PubMed
16988228
Passive immunization with a multicomponent vaccine against conserved domains of apical membrane antigen 1 and 235-kilodalton rhoptry proteins protects mice against Plasmodium yoelii blood-stage challenge infection.
Infect Immun2006https://conductscience.org/library/papers/16988228PubMed
11796616Protective immune responses to the 42-kilodalton (kDa) region of Plasmodium yoelii merozoite surface protein 1 are induced by the C-terminal 19-kDa region but not by the adjacent 33-kDa region.Infect Immun2002https://conductscience.org/library/papers/11796616PubMed
11796601Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.Infect Immun2002https://conductscience.org/library/papers/11796601PubMed
10992516Immunization with recombinant Plasmodium yoelii merozoite surface protein 4/5 protects mice against lethal challenge.Infect Immun2000https://conductscience.org/library/papers/10992516PubMed
10768987
Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection.
Infect Immun2000https://conductscience.org/library/papers/10768987PubMed

See all 21 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9673281

GET https://conductscience.org/api/papers/v1/9673281/references?page=2